Overview

Inhaled Nitric Oxide and Neuroprotection in Premature Infants

Status:
Active, not recruiting
Trial end date:
2021-06-07
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether inhaled nitric oxide improves the neurological outcome for premature infants.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Chicago
Treatments:
Nitric Oxide
Criteria
Inclusion Criteria:

- Prematurity (birthweight ≤ 1500g, < 31 weeks gestation)

- Requiring respiratory support

- Admitted to the NICU at the University of Chicago

Exclusion Criteria:

- Severe congenital anomalies

- Genetic syndromes

- Extremely sick preterm infants requiring very high ventilatory pressures (OI ≥ 20)

- Premature infants judged by the physician as nonviable